Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
Alliance Foundation Trials, LLC.
Mayo Clinic
University of Chicago
Hospices Civils de Lyon
Centre Leon Berard
Cancer Research UK
NuCana plc
Esperas Pharma Inc.
Stanford University
Vall d'Hebron Institute of Oncology
Peking Union Medical College Hospital
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Centre Leon Berard
Western Sydney Local Health District
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
University of Chicago
Imperial College London
Sun Yat-sen University
Mayo Clinic
AGO Study Group